INS and Hypoglycemia: The models themselves pursue five practical outputs that map neatly onto the clinical pathway: (i) near-term glucose forecasting (nocturnal hypoglycemia, post-prandial spikes) [1,11,13], (ii) automated, individualized insulin dosing via closed-loop/artificial-pancreas systems [3,16,22].